Sg Americas Securities, LLC Nuvation Bio Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 72,057 shares of NUVB stock, worth $168,613. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,057

Previous 31,916 125.77%

Holding current value

$168,613

Previous $93,000 77.42%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$2.3 - $3.83 $92,324 - $153,740	40,141 Added 125.77%	72,057 $165,000
Q2 2024 Jul 12, 2024	SELL	$2.58 - $3.69 $48,271 - $69,039	-18,710 Reduced 36.96%	31,916 $93,000
Q1 2024 May 06, 2024	SELL	$1.46 - $3.97 $42,307 - $115,042	-28,978 Reduced 36.4%	50,626 $184,000
Q4 2023 Jan 12, 2024	SELL	$0.96 - $1.53 $29,397 - $46,851	-30,622 Reduced 27.78%	79,604 $120,000
Q3 2023 Oct 13, 2023	BUY	$1.26 - $2.1 $125,286 - $208,811	99,434 Added 921.37%	110,226 $148,000
Q2 2023 Jul 10, 2023	SELL	$1.56 - $1.84 $22,654 - $26,720	-14,522 Reduced 57.37%	10,792 $19,000
Q1 2023 Apr 28, 2023	BUY	$1.6 - $2.48 $7,756 - $12,023	4,848 Added 23.69%	25,314 $42,000
Q4 2022 Feb 02, 2023	SELL	$1.68 - $2.5 $340,309 - $506,412	-202,565 Reduced 90.82%	20,466 $39,000
Q3 2022 Oct 31, 2022	BUY	$0.29 - $4.04 $18,371 - $255,938	63,351 Added 39.67%	223,031 $500,000
Q2 2022 Jul 29, 2022	SELL	$3.24 - $5.85 $767,095 - $1.39 Million	-236,758 Reduced 59.72%	159,680 $517,000
Q1 2022 Apr 29, 2022	SELL	$4.6 - $8.83 $655,104 - $1.26 Million	-142,414 Reduced 26.43%	396,438 $2.09 Million
Q4 2021 Feb 07, 2022	BUY	$7.75 - $10.05 $3.95 Million - $5.12 Million	509,929 Added 1763.06%	538,852 $4.58 Million
Q3 2021 Nov 01, 2021	BUY	$7.78 - $10.0 $225,020 - $289,230	28,923 New	28,923 $287,000

Others Institutions Holding NUVB

# of Institutions

152

Shares Held

123M

Call Options Held

9.7K

Put Options Held

6.5K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $508M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Nuvation Bio Inc. Transaction History